Search

everythinglearnresearchcommunity

for

Search:↓

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

New treatments targeting insulin, blood flow, and inflammation could improve hormone-related hair conditions with fewer side effects.

Men's hair loss is not linked to their sex hormone levels, except for lower DHEAS in those with hair loss.

Glypican-4 may help indicate insulin sensitivity and lipid issues in women with PCOS.

Exercise, especially vigorous aerobic and resistance training, can improve hormone levels in women with PCOS.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Lean and obese women with PCOS have similar levels of insulin resistance, indicating it's a core aspect of the condition.

Sex hormones likely don't affect atopic dermatitis in adolescents and adults.

Exercise and finasteride together improve ovary health in PCOS rats.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Green tea may help relieve PCOS symptoms, but more research is needed.

Nanotechnology can help manage PCOS by reducing inflammation and improving hormone balance.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

The paper concludes that animal models help in understanding hair loss causes and developing new treatments.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

The new rodent model successfully mimics non-lean human PCOS symptoms.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

Metformin helps treat PCOS by improving fertility, reducing symptoms, and regulating periods.

Melatonin may help manage PCOS by improving insulin sensitivity, hormone balance, and mood.

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.

Metformin reduces certain hormone levels in men with early-onset hair loss.

Androgen receptors significantly affect hair loss in women with androgenetic alopecia.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Levothyroxine is less effective in men with early-onset male-pattern baldness.